Simon, F., Ligtvoet, R., Fürstenau, M., Robrecht, S., Zhang, C., Kutsch, N., Tresckow, J. V., Goede, V., Fink, A. M., Staber, P., Noesslinger, T., Poulsen, C., Illmer, T., Müller, L., Vehling-Kaiser, U., Eckart, M., Sivcheva, L., Loscertales, J., Jentsch-Ullrich, K., Hebart, H., Levin, M., Cunha-Bang, C. D., Tausch, E., Schneider, C., Stilgenbauer, S., Kater, A., Niemann, C., Fischer, K., Cramer, P., Langerbeins, P., Hallek, M., Eichhorst, B., Al-Sawaf, O. (2025). Redefining early vs late progressive disease (PD) in chronic lymphocytic leukemia: A pooled analysis of fixed-duration therapies. Blood. https://doi.org/10.1182/blood-2025-2107